Skip to main content
. 2013 Mar 3;15(6):783–787. doi: 10.1093/neuonc/not021

Table 3.

Cumulative toxicities assesseda (N = 22)

Toxicity Grade
Toxicity term 1 2 3 4 5
Nausea 11 2
Vomiting 8 2 1
Fatigue 7 1
Headache 4
Anorexia 3 1
Abdominal pain 3
Pruritus 3
Constipation 2 1
Lymphopenia 1 1 1
Ataxia 1 1
Rash 1 1
Extrapyramidal/involuntary movement 2
Hemiparesis 2
Neurology–motor (gait) 1 1
Neutropenia 1 (DLT)
Alopecia 1
Cushingoid appearance 1
Fever 1
Striae 1
Diarrhea 1
Infection 1
Tinnitus 1
Tachypnea 1
Insomnia 1
Hypertension 1
Mucositis 1
Prolonged QTc 1
Neuropathy–sensory 1
Hypokalemia 1
Hypomagnesemia 1
Cough 1
Allergic reaction 1
Leukopenia 1
Flushing 1
Cardiac–other (T-wave abnormality) 1

aAccording to the Common Terminology Criteria for Adverse Events, version 3.0 for all findings with a possible, probably, or definite attribution to ATO administration in the 22 patients evaluable for toxicity.